Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 3462
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT05847192 Tau Networks in Psychotic Alzheimer's Disease |
Tau Networks in Psychotic Alzheim… | Alzheimer | À vérifier | RECRUITING | En attente / non publié | Northwell Health | United States · The Feinstein Institutes for Medical … | 2023-04-13 → 2029-12-31 | Ouvrir |
| NCT01078636 ADNI-GO — Alzheimer's Disease Neuroimaging Initiative Grand Opportunity |
ADNI-GO — Alzheimer's Disease Neu… | Alzheimer | À vérifier | COMPLETED | En attente / non publié | Alzheimer's Disease Cooperative S… | United States, Canada · Albany Medical College, Alban… | 2010-04 → 2012-10 | Ouvrir |
| NCT00006337 KW-6002 to Treat Parkinson's Disease |
KW-6002 | Parkinson | Phase 2 | COMPLETED | En attente / non publié | National Institute of Neurologica… | United States · National Institute of Neurological Di… | 2000-10 → 2002-01 | Ouvrir |
| NCT05853471 [18F]MC225-PET in Neurodegenerative Disease |
[18F]MC225 | Alzheimer | Phase 1 | UNKNOWN | En attente / non publié | University Medical Center Groning… | Netherlands · University Medical Center Groningen, Gr… | 2022-02-01 → 2024-01-01 | Ouvrir |
| NCT00196911 STN-Stimulation Versus Best Medical Treatment in Advanced PD |
Implantation of stimulation elect… | Parkinson | Phase 3 | COMPLETED | En attente / non publié | German Parkinson Study Group (GPS) | Germany · Department of Neurology, Schittenhelmstr. 1… | 2001-01 → 2005-01 | Ouvrir |
| NCT03358472 Pembrolizumab Plus Epacadostat, Pembrolizumab Monotherapy, and the EXTR… |
Pembrolizumab | Parkinson | Phase 3 | COMPLETED | En attente / non publié | Merck Sharp & Dohme LLC | United States, Australia, Austria, Canada, Hungary, I… | 2017-12-01 → 2025-10-30 | Ouvrir |
| NCT03575195 MICRO-PD — Microbiota Intervention to Change the Response of Parkinson'… |
Rifaximin | Parkinson | Phase 1 | SUSPENDED | En attente / non publié | University of California, San Fra… | United States · University of California San Francisc… | 2019-07-15 → 2026-08 | Ouvrir |
| NCT05762003 CPE — Czech Pharmaco-epidemiological Study on Disease Modifying Drugs |
interferons, glatiramer acetate, … | SEP | À vérifier | COMPLETED | En attente / non publié | IMPULS Endowment Fund | Czechia · IMPULS Endowment Fund, Prague, Czechia | 2019-01-01 → 2021-12-31 | Ouvrir |
| NCT03853746 Short-term B-cell Depletion in Relapsing Multiple Sclerosis |
Ocrelizumab | SEP | Phase 4 | COMPLETED | En attente / non publié | Hoffmann-La Roche | United States · Johns Hopkins University, Baltimore, … | 2019-04-01 → 2024-07-01 | Ouvrir |
| NCT03535298 DELIVER-MS — Determining the Effectiveness of earLy Intensive Versus Es… |
Early Highly Effective Therapies … | SEP | Phase 4 | ACTIVE_NOT_RECRUITING | En attente / non publié | The Cleveland Clinic | United States, United Kingdom · Aneurin Bevan Local H… | 2019-01-03 → 2027-07-30 | Ouvrir |
| NCT03157830 OCTAVE — Evaluating the Efficacy and Safety of Transitioning Patients F… |
OCTAVE — Evaluating the Efficacy … | SEP | À vérifier | COMPLETED | En attente / non publié | Providence Health & Services | United States · Kadlec Neuroscience Center, Richland,… | 2017-06-01 → 2022-06-06 | Ouvrir |
| NCT05334472 A Survey to Evaluate Early Experience From Patient and Care Partner on … |
A Survey to Evaluate Early Experi… | SEP | À vérifier | COMPLETED | En attente / non publié | Novartis Pharmaceuticals | United States · Novartis Investigative Site, East Han… | 2021-11-24 → 2023-02-15 | Ouvrir |
| NCT01723631 TRAP-Myéline — Analyze the Myelin-TRAP as Diagnostic Tool in Multiple S… |
Trap Myelin Test | SEP | NA | TERMINATED | En attente / non publié | Nantes University Hospital | France · Hopital neurologigue Pierre Wertheimer, Bron… | 2012-04 → 2015-10 | Ouvrir |
| NCT04379193 Physical Therapy and Neuroactive Steroids Therapy Does Not Modulate Ser… |
Physical Therapy and Neuroactive … | SEP | NA | COMPLETED | En attente / non publié | Charles University, Czech Republic | Non communiqué | 2015-05-20 → 2019-09-01 | Ouvrir |
| NCT00258609 Dysport® In Migraine Without Aura Prophylaxis : DIMWAP Study |
Botulinum Toxin type A (Dysport ®… | Migraine | Phase 3 | COMPLETED | En attente / non publié | Department of Medical Services Mi… | Thailand · Department of Medicine, Sappasithiprasong … | 2003-02 → 2004-06 | Ouvrir |
| NCT00301665 Efficacy and Safety Study of Dysport® Used for Migraine Prophylaxis |
Botulinum toxin type A | Migraine | Phase 2 | COMPLETED | En attente / non publié | Ipsen | Czechia, Poland, Slovakia · Air Force Institute of Av… | 2003-02 → 2005-03 | Ouvrir |
| NCT06448676 Head-to-Head Comparison of All Botulinum Neurotoxin Type A Products for… |
Botulinum toxin type A | Migraine | Phase 4 | RECRUITING | En attente / non publié | Ipsen | Netherlands · Faceland, Amsterdam, Netherlands | Face… | 2026-02-02 → 2027-02-01 | Ouvrir |
| NCT00372879 Clinical Trial of Vitamin E to Treat Muscular Cramps in Patients With A… |
Clinical Trial of Vitamin E to Tr… | Sclérose latérale amyotrophique | Phase 3 | COMPLETED | En attente / non publié | London Health Sciences Centre Res… | Canada · London Health Sciences Centre, London, Canada | 2006-12 → 2010-08 | Ouvrir |
| NCT04455542 Peripheral Neurofilament Levels and Amyotrophic Lateral Sclerosis |
Peripheral Neurofilament Levels a… | Sclérose latérale amyotrophique | À vérifier | COMPLETED | En attente / non publié | Peking University Third Hospital | China · Peking University Third Hospital, Beijing, Ch… | 2017-08-01 → 2019-05-01 | Ouvrir |
| NCT03865420 Amyotrophic Lateral Sclerosis (ALS) Families Project |
Amyotrophic Lateral Sclerosis (AL… | Sclérose latérale amyotrophique | À vérifier | RECRUITING | En attente / non publié | Columbia University | United States · Columbia University, New York, United… | 2018-09-11 → 2027-01 | Ouvrir |
| NCT02881489 UwmBmmscALS — Autologous Bone Marrow Mesenchymal Stem Cells in the Trea… |
UwmBmmscALS — Autologous Bone Mar… | Sclérose latérale amyotrophique | Phase 1 | UNKNOWN | En attente / non publié | University of Warmia and Mazury | Non communiqué | 2015-11 → 2018-12 | Ouvrir |
| NCT01793168 CoRDS — Rare Disease Patient Registry & Natural History Study - Coordin… |
CoRDS — Rare Disease Patient Regi… | Myasthénie | À vérifier | RECRUITING | En attente / non publié | Sanford Health | United States, Australia · Online Patient Enrollment … | 2010-07 → 2100-12 | Ouvrir |
| NCT06836973 Blinatumomab for Treatment of Refractory Myasthenia Gravis |
Blinatumomab | Myasthénie | Phase 2 | NOT_YET_RECRUITING | En attente / non publié | Amgen | Non communiqué | 2025-04-01 → 2028-06-30 | Ouvrir |
| NCT02317224 The Safety and Efficacy of "3-Hole" Subxiphorid Approach in the Treatme… |
"3-Hole" subxiphorid and subcosta… | Myasthénie | Phase 2 | UNKNOWN | En attente / non publié | Tang-Du Hospital | China · Tangdu hospital, Xi'an, China | 2014-08 → 2024-12 | Ouvrir |
| NCT02466217 TRANSIMMUNOM — Phenomics in Autoimmune and Inflammatory Diseases |
TRANSIMMUNOM — Phenomics in Autoi… | Myopathies | À vérifier | COMPLETED | En attente / non publié | Assistance Publique - Hôpitaux de… | France · CIC Paris-Est, Hôpital PITIE SALPETRIERE, Pa… | 2015-07-29 → 2022-07-18 | Ouvrir |